- $6.57m
- $3.52m
- $5.31m
- 55
- 48
- 31
- 41
Annual balance sheet for Biomerica, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2021 May 31st | R2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4.2 | 5.92 | 9.72 | 4.17 | 2.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.46 | 0.774 | 0.722 | 0.947 | 0.731 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 9.23 | 9.43 | 12.8 | 7.73 | 4.88 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.86 | 1.52 | 1.25 | 0.943 | 0.564 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 11.8 | 11.4 | 14.5 | 9.25 | 5.95 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.3 | 2.01 | 1.95 | 2.2 | 1.74 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.59 | 3.05 | 2.73 | 2.66 | 1.84 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9.23 | 8.32 | 11.7 | 6.59 | 4.11 |
| Total Liabilities & Shareholders' Equity | 11.8 | 11.4 | 14.5 | 9.25 | 5.95 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |